Available option
10mg
Lyophilised powder
- Strength
- 10mg
- Format
- Lyophilised powder
Bear Biotech catalogue
PT-141 / Bremelanotide
Melanocortin receptor agonist research material
- Melanocortin signalling
- Bremelanotide identity
- Approved-product distinction
Available presentations
Choose a strength and format
Each available presentation is listed separately. Current prices are confirmed from the Bear Biotech catalogue.
Research overview
What is PT-141 / Bremelanotide?
PT-141, also known as bremelanotide, is a melanocortin receptor agonist studied for central melanocortin signalling rather than pigmentation-focused research alone. The active moiety has an approved U.S. pharmaceutical context, but a Bear Biotech research vial is not that approved product and should not inherit its therapeutic claims.
Approved active moiety in a specific U.S. product; research vial is not that product
Research focus
Key research areas
PT-141 research: melanocortin signalling beyond pigmentation
PT-141 is a research name associated with bremelanotide, a melanocortin-receptor agonist. Evidence for a defined regulated formulation does not establish equivalence of generic research material. Published findings concern defined experimental materials and do not establish the identity, quality, safety, efficacy or equivalence of Bear Biotech catalogue material.
- Melanocortin signalling
- Bremelanotide identity
- Approved-product distinction
Representative primary research
Representative research
A randomised double-blind crossover study compared a single PT-141 exposure with placebo.
- Subjective sexual response in premenopausal women following bremelanotide (PT-141) ↗ Original controlled research on the exact compound.
These sources provide research context only. They do not verify the identity, quality or equivalence of a Bear Biotech catalogue batch; the matched lot-specific batch record remains controlling.
Specifications
Product information
- Material identity
- PT-141 / Bremelanotide
- Research category
- Melanocortin receptor agonist research material
- Evidence position
- Approved active moiety in a specific U.S. product; research vial is not that product
- Recorded formats
- Lyophilised powder
- Batch-record basis
- The matched lot-specific record controls identity and analytical claims.
- Intended use
- Controlled laboratory research only.
Research questions
Evidence and identity questions
Which melanocortin pathways define PT-141 research?
PT-141 / Bremelanotide is studied through melanocortin-receptor signalling. Research questions depend on receptor pharmacology and exact material identity.
Why is a PT-141 research vial not interchangeable with an approved bremelanotide product?
PT-141 / Bremelanotide is an approved active moiety in a specific United States product, but that product context does not transfer to a generic research vial.
Which material and formulation limits apply to PT-141 evidence?
PT-141 / Bremelanotide evidence includes defined clinical and preclinical work. Interpretation must keep approved-product identity, formulation and research material distinct.
Batch documentation
Lot-specific records stay connected to the order
Eligible lot-specific documentation may be viewed or requested from the registered Bear Biotech account when available for the applicable order.
Open Bear Biotech accountResearch use only
Controlled laboratory research material
Not for human or veterinary consumption. Administration, dosing and therapeutic guidance are not provided.